Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351754 · ClinicalTrials.gov registry record · Phase 4
Detection of Pulmonary Embolism With CECT
A Phase 4 study of Pulmonary Embolism, sponsored by Bracco Diagnostics.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT00351754: Completed Phase 4 study of Pulmonary Embolism, sponsored by Bracco Diagnostics.
NCT00351754 is a Phase 4 study of Pulmonary Embolism that has completed, run by Bracco Diagnostics. The registered enrollment target is 120 participants, below the 3,056-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00351754, a Phase 4 study of Pulmonary Embolism, has completed, sponsored by Bracco Diagnostics.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA
Conditions Studied
Interventions
- DRUG Isovue
Study Locations (1)
New Jersey
- Bracco Diagnostics, Inc. - Princeton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2006-07 |
| Est. Completion | 2006-11 |
| Phase | Phase 4 |
What the finished NCT00351754 record still lists
NCT00351754 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 3,056-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Isovue is the first listed.
NCT00351754 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT00351754 about?
NCT00351754 is a clinical study titled "Detection of Pulmonary Embolism With CECT". To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA
What is the current status of trial NCT00351754?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2006-07. Estimated completion is 2006-11.
What conditions does trial NCT00351754 study?
This clinical trial studies the following conditions: Pulmonary Embolism.
What interventions are being tested in trial NCT00351754?
The interventions under investigation include: Isovue (DRUG).
Who is sponsoring clinical trial NCT00351754?
This trial is sponsored by Bracco Diagnostics, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00351754 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00351754's enrollment target sits among peer trials
120 33rd of 48 higher than 16 of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
ACTIVE NOT RECRUITING · Phase 4
-
Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism
ACTIVE NOT RECRUITING · Phase 4
-
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
ACTIVE NOT RECRUITING · Phase 4
-
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy
COMPLETED · Phase 4
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia